Riskpilot← Back to searchSign inGet full accessCELLMAX TECHNOLOGIES AB
ABActiveOrg 5566144316Gullfossgatan 1 AWholesale of information and communication equipment · NACE 4650Est. 200130 employees
Revenue 2024
SEK 247,4M
+26% vs 2023
EBITDA margin
-0.3%
-163% vs 2023
Equity ratio
72.5%
Financial strength
Net profit 2024
SEK -4,6M
-938% vs 2023
| Revenue | SEK 247,4M | +26% |
| EBITDA | SEK -697K | -163% |
| Net profit | SEK -4,6M | -938% |
| Total assets | SEK 221,6M | +17% |
| Equity | SEK 160,7M | -3% |
| Employees | 30 | — |
Legal name
CELLMAX TECHNOLOGIES AB
Org number
5566144316
Legal form
Aktiebolag
NACE code
4650 · Wholesale of information and communication equipment
Founded
14 augusti 2001
Share capital
SEK 5 735 000
Employees
30 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva produktionsutveckling och försäljning främst inom telekomsektorn samt äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Gullfossgatan 1 A
Email
naadede.tettey@cellmax.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | 146 607 | 143 059 | 219 216 | 479 391 | 277 214 | 347 342 | 357 230 | 196 730 | 247 380 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 28 868 | −31 489 | −30 828 | −21 640 | 80 994 | 49 157 | 35 943 | 21 892 | 1 111 | −697 |
| Depreciation & amort. | −10 384 | −11 234 | −7 320 | −6 545 | −6 800 | −5 505 | −5 117 | −5 456 | −4 500 | −3 275 |
| EBIT | 18 484 | −42 723 | −38 148 | −28 185 | 74 194 | 43 652 | 30 826 | 16 436 | −3 389 | −3 972 |
| Net financials | −270 | −262 | −751 | −1 124 | −3 175 | −513 | −187 | −209 | 1 225 | −598 |
| Profit before tax | 18 214 | −42 986 | −38 899 | −29 308 | 71 019 | 43 139 | 30 639 | 14 502 | −440 | −4 569 |
| Tax | −46 | −104 | −11 | −0 | −0 | −0 | −4 160 | −800 | −0 | −0 |
| Net profit | 18 168 | −43 090 | −38 910 | −29 308 | 71 019 | 43 139 | 26 479 | 13 702 | −440 | −4 569 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 172 435 | 123 039 | 119 508 | 152 720 | 246 686 | 237 099 | 208 962 | 246 988 | 189 774 | 221 646 |
| Equity | 117 712 | 80 053 | 40 798 | 11 334 | 82 352 | 125 491 | 151 970 | 165 673 | 165 233 | 160 663 |
| Long-term debt | 0 | 7 000 | 24 000 | 29 880 | 880 | 880 | 880 | 880 | 880 | 880 |
| Short-term debt | 54 723 | 35 985 | 54 710 | 111 507 | 163 454 | 103 533 | 50 917 | 74 615 | 22 156 | 55 098 |
| Total debt | 54 723 | 42 985 | 78 710 | 141 387 | 164 334 | 104 413 | 51 797 | 75 495 | 23 036 | 55 978 |
EBITDA margin
-0.3%
This company
15.8%
Market median
-102% vs market
20152024
Equity ratio
72.5%
This company
38.2%
Market median
+90% vs market
20152024
Return on equity
-2.8%
This company
18.4%
Market median
-115% vs market
20152024
Net profit margin
-1.8%
This company
8.1%
Market median
-122% vs market
20152024
Asset turnover
1.12×
This company
1.12×
Market median
+0% vs market
20152024
Debt / equity
0.38×
This company
0.62×
Market median
+39% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ND Authorized Recipient of Service | Authorized Recipient of Service | 2022 | — | — |
HA Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
NR Chief Executive Officer | Chief Executive Officer | 2022 | — | — |
AO Chief Auditor | Chief Auditor | 2022 | — | — |
SJ Chief Auditor | Chief Auditor | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2022 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
ROSENBERGER HOCHFREQUENTZTECHNIC GMBH | Company | 100.0% | 100.0% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
ROSENBERGER HOCHFREQUENTZTECHNIC GMBH
CELLMAX TECHNOLOGIES AB (this company)Board members of CELLMAX TECHNOLOGIES AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Naa Dede Onigi Tettey | Authorized Recipient of Service | 0 companies |
| Hammad Abu Iseifan | Chief Executive Officer | 0 companies |
| Nils Reine Eriksson | Chief Executive Officer | 0 companies |
| Anton Ola Spinnars | Chief Auditor | 0 companies |
| Sten Johan Pharmanson | Chief Auditor | 0 companies |
| Hans Georg Rosenberger | Board of Directors | 0 companies |
| Josef Nikolaus Rottenaicher | Board of Directors | 0 companies |
| Marc Friedrich Käumle | Chairman | 0 companies |
| Eric Küppers | Board of Directors | 0 companies |
| Peter Michael Rosenberger | Board of Directors | 0 companies |